Veritas In Silico Inc. 130AShort Interest

No institution currently reports a short position of 0.5% or more in Veritas In Silico Inc. (130A). The last disclosure was on 2026-11-09 (Morgan Stanley MUFG Securities Co., Ltd., 0.33%).

Growth Market(Domestic) Pharmaceutical Pharmaceutical
Estimated short interest
0.00%
±0.00%
Estimated position (shares)
0
As of 2026-11-18
Holders (0.5% or more)
0 firms
295 reports

Estimated short interest is the sum of positions of 0.5% or more reported within the past year. It also excludes 7 institutions that fell below 0.5%. How estimates are calculated

Disclosure History Summary

First disclosure2024-02-15
Latest disclosure2026-11-09 (Morgan Stanley MUFG Securities Co., Ltd., 0.33%)
Reporting institutions7 firms (295 reports)
Peak estimated short interest4.56% (2024-08-01, 2 holders)

Short Interest Trend Last 5 years, by institution, % of shares outstanding

Estimated short interest stacked by institution, counting only positions of 0.5% or more reported within the past year. The 5 largest current holders are colored and the rest are grouped as "Others". Hover over (or tap) a bar to see the breakdown.

  • Integrated Core Strategies (Asia) Pte. Ltd.
  • Morgan Stanley MUFG Securities Co., Ltd.
  • UBS AG
  • Barclays Capital Securities Ltd
  • MERRILL LYNCH INTERNATIONAL
  • Others
0.00%
Estimated short interest, 2026-11-18

Current Positions by Short Seller Latest report of each holder

Last report Short seller Position (shares) Ratio Change Status
2026-01-28 UBS AG Position 30,500 shares Ratio 0.47% ▼0.03% −2,200 Below 0.5%
2026-04-15 MERRILL LYNCH INTERNATIONAL Position 29,100 shares Ratio 0.44% ▼0.07% −4,000 Below 0.5%
2026-06-19 Barclays Capital Securities Ltd Position 27,300 shares Ratio 0.42% ▼0.17% −11,600 Below 0.5%
2024-10-22 Integrated Core Strategies (Asia) Pte. Ltd. Position 25,600 shares Ratio 0.39% ▼0.18% −11,800 Below 0.5%
2025-08-05 Nomura International plc Position 23,800 shares Ratio 0.36% ▼0.35% −22,900 Below 0.5%
2026-11-09 Morgan Stanley MUFG Securities Co., Ltd. Position 21,600 shares Ratio 0.33% ▼0.26% −16,700 Below 0.5%
2026-10-29 GOLDMAN SACHS INTERNATIONAL Position 19,800 shares Ratio 0.30% ▼0.21% −13,800 Below 0.5%

Disclosure History 295 in total

Trade date Short seller Position (shares) Ratio Change Note
2026-11-09 Morgan Stanley MUFG Securities Co., Ltd. Position 21,600 shares Ratio 0.33% ▼0.26% −16,700 Below 0.5%
2026-10-30 Morgan Stanley MUFG Securities Co., Ltd. Position 38,300 shares Ratio 0.59% ▼0.17% −11,500 —
2026-10-29 GOLDMAN SACHS INTERNATIONAL Position 19,800 shares Ratio 0.30% ▼0.21% −13,800 Below 0.5%
2026-10-29 Morgan Stanley MUFG Securities Co., Ltd. Position 49,800 shares Ratio 0.76% ▼0.20% −12,900 —
2026-10-26 Morgan Stanley MUFG Securities Co., Ltd. Position 62,700 shares Ratio 0.96% ▲0.12% +8,100 —
2026-10-22 GOLDMAN SACHS INTERNATIONAL Position 33,600 shares Ratio 0.51% ▲0.06% —
2026-10-22 Morgan Stanley MUFG Securities Co., Ltd. Position 54,600 shares Ratio 0.84% ▲0.20% +13,000 —
2026-10-21 Morgan Stanley MUFG Securities Co., Ltd. Position 41,600 shares Ratio 0.64% ▲0.35% +13,300 —
2026-07-29 Morgan Stanley MUFG Securities Co., Ltd. Position 28,300 shares Ratio 0.43% ▼0.08% −5,000 Below 0.5%
2026-06-19 Barclays Capital Securities Ltd Position 27,300 shares Ratio 0.42% ▼0.17% −11,600 Below 0.5%
2026-06-15 Morgan Stanley MUFG Securities Co., Ltd. Position 33,300 shares Ratio 0.51% ▲0.11% +2,200 —
2026-06-11 Barclays Capital Securities Ltd Position 38,900 shares Ratio 0.59% ▼0.10% −6,400 —
2026-06-04 Barclays Capital Securities Ltd Position 45,300 shares Ratio 0.69% ▲0.09% −400 —
2026-06-03 Barclays Capital Securities Ltd Position 45,700 shares Ratio 0.70% ▲0.10% +6,300 —
2026-05-29 Barclays Capital Securities Ltd Position 39,400 shares Ratio 0.60% ▲0.07% +4,600 —
2026-05-22 Morgan Stanley MUFG Securities Co., Ltd. Position 31,100 shares Ratio 0.47% ▼0.12% −7,700 Below 0.5%
2026-05-20 Morgan Stanley MUFG Securities Co., Ltd. Position 38,800 shares Ratio 0.59% ▼0.08% −4,700 —
2026-05-19 Morgan Stanley MUFG Securities Co., Ltd. Position 43,500 shares Ratio 0.67% ▼0.12% −8,000 —
2026-05-14 Barclays Capital Securities Ltd Position 34,800 shares Ratio 0.53% ▲0.07% +4,600 —
2026-05-01 Barclays Capital Securities Ltd Position 30,200 shares Ratio 0.46% ▼0.07% −4,800 Below 0.5%
2026-04-30 Barclays Capital Securities Ltd Position 35,000 shares Ratio 0.53% ▲0.04% +2,600 —
2026-04-28 Barclays Capital Securities Ltd Position 32,400 shares Ratio 0.49% ▼0.12% −7,200 Below 0.5%
2026-04-21 Barclays Capital Securities Ltd Position 39,600 shares Ratio 0.61% ▲0.07% +4,400 —
2026-04-16 Barclays Capital Securities Ltd Position 35,200 shares Ratio 0.54% ▲0.05% +3,000 —
2026-04-15 MERRILL LYNCH INTERNATIONAL Position 29,100 shares Ratio 0.44% ▼0.07% −4,000 Below 0.5%
2026-04-15 Barclays Capital Securities Ltd Position 32,200 shares Ratio 0.49% ▼0.05% −3,200 Below 0.5%
2026-04-14 MERRILL LYNCH INTERNATIONAL Position 33,100 shares Ratio 0.51% ▼0.12% −8,000 —
2026-04-13 MERRILL LYNCH INTERNATIONAL Position 41,100 shares Ratio 0.63% ▼0.16% −10,500 —
2026-04-13 Barclays Capital Securities Ltd Position 35,400 shares Ratio 0.54% ▲0.13% +8,200 —
2026-04-10 MERRILL LYNCH INTERNATIONAL Position 51,600 shares Ratio 0.79% ▼0.09% −5,800 —

Shorted Stocks in the Same Industry Pharmaceutical

Stock Estimated ratio Short sellers
GNI Group Ltd.2160 11.16% 7 firms
Oncolys BioPharma Inc.4588 10.35% 7 firms
HEALIOS K.K.4593 10.20% 5 firms
SymBio Pharmaceuticals Limited4582 9.46% 7 firms
Nxera Pharma Co.,Ltd.4565 7.35% 5 firms

Related Stocks Same TSE 33 sector